Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

002118

CNE000001R43

Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Appoints Chen Fu as Non-Independent Directors

January 16, 2023 at 07:32 pm

Jilin Zixin Pharmaceutical Industrial Co.,Ltd. appointed Chen Fu as non-independent directors at its 1st Extraordinary General Meeting of 2023 on 13 January 2023.

Latest news about Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(SZSE:002118) dropped from Shenzhen Stock Exchange A Share Index	04/08/23	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(SZSE:002118) dropped from Shenzhen Stock Exchange Composite Index	04/08/23	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Approves Board Appointments	30/05/23	CI
Jilin Zixin Pharma CFO Resigns; Successor Named; Shares Slump 5%	11/05/23	MT
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Auditor Raises 'Going Concern' Doubt	07/05/23	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23	CI
Jilin Zixin Pharma Chairman Resigns	19/04/23	MT
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Appoints Chen Fu as Non-Independent Directors	16/01/23	CI
Jilin Zixin Pharma Elects Chairman	16/01/23	MT
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	25/10/22	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/07/22	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/06/22	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Auditor Raises 'Going Concern' Doubt	28/06/22	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Announces Board Changes	24/05/22	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	24/02/22	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	28/10/21	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	29/08/21	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	29/04/21	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	23/04/21	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(XSEC:002118) dropped from S&P Global BMI Index	21/12/20	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(SZSE:002118) dropped from Shenzhen Stock Exchange Component A Share Index	14/12/20	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd.(SZSE:002118) dropped from Shenzhen Stock Exchange Component Index	11/12/20	CI
Jilin Zixin Pharmaceutical Industrial Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	27/10/20	CI
Jilin Hengde Investment Information Consulting Co., Ltd. agreed to acquire Jilin Zixin Dunhua Medicine & Herbs Co., Ltd. from Jilin Zixin Pharmaceutical Industrial Co.,Ltd. for CNY 1 million.	27/08/20	CI

Chart Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

Duration

Period

Chart Jilin Zixin Pharmaceutical Industrial Co.,Ltd.

More charts

JILIN ZIXIN PHARMACEUTICAL INDUSTRIAL CO., LTD is a China-based company, principally engaged in the research and development, production and distribution of traditional Chinese patent drugs and ginseng products. The Company operates its businesses through three segments. The Traditional Chinese Patent Drugs segment mainly provides traditional Chinese patent drugs for the treatment of rheumatoid immunity, ear-nose-throat (ENT), urinary system cardiovascular, hepatobiliary and digestive diseases. The Ginseng Products segment is engaged in the provision of deep processing products and rough-wrought products, including white ginseng products, red ginseng products, drinks and candied fruits. The Gene Sequencing segment is engaged in the research and development, manufacture and distribution of gene sequencing machines and supporting reagents.

Sector

Pharmaceuticals

More about the company

Sector Alternative Medicine

	1st Jan change	Capi.
DONG-E-E-JIAO CO.,LTD.	+37.29%	6.02B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-21.28%	4.19B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+4.52%	3.25B
TASLY PHARMACEUTICAL GROUP CO., LTD	-18.16%	2.87B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-7.70%	2.37B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+41.50%	1.89B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-4.05%	1.58B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-15.56%	1.54B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-14.62%	1.5B

Alternative Medicine